declares having received research grants through his affiliation from Novo Nordisk and Pharmaserve Lilly, and consulting honoraria from Pharmaserve Lilly, Sanofi-Aventis, Novo Nordisk, MSD, AstraZeneca, ELPEN Pharma, Boehringer Ingelheim, Galenica Pharma, Epsilon Health and WinMedica
Explore We create standards every day that guarantee individual service with a local character at all times
Researchers have also questioned whether the form of B12 may make a difference
With FDA input pending, the companies are targeting a Phase 3 trial launch in the first half of 2026
A 23-week randomized clinical trial found that participants taking 1 mg of AOD-9604 daily lost an average of 6.2 pounds compared to 1.8 pounds in the placebo group